Ji Zhang
- Cancer Research top 2%
- Cancer-related molecular mechanisms research 22
- MicroRNA in disease regulation 15
- Molecular Biology top 5%
- Circular RNAs in diseases 13
- RNA modifications and cancer 12
- Epigenetics and DNA Methylation 6
- Oncology top 10%
- Hematology top 10%
- Acute Myeloid Leukemia Research 9
- Chronic Myeloid Leukemia Treatments 6
- Immunology top 10%
-
- Autophagy in Disease and Therapy 7
- Journals
- Proceedings of the National Academy of Sciences (1 paper)SHILAP Revista de lepidopterología (2 papers)Blood (2 papers)
- Partner nations
- ChinaUnited StatesEthiopia
In The Last Decade
Ji Zhang
109 papers receiving 2.5k citations
Hit Papers
Peers
Comparison fields: 5 of 131
- Cancer Research 654
- Molecular Biology 1.5k
- Oncology 358
- Hematology 139
- Immunology 256
Countries citing papers authored by Ji Zhang
This map shows the geographic impact of Ji Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ji Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ji Zhang more than expected).
Fields of papers citing papers by Ji Zhang
This network shows the impact of papers produced by Ji Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ji Zhang. The network helps show where Ji Zhang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ji Zhang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 8 | |
| 2 | 2024 | 4 | |
| 3 | 2024 | 2 | |
| 4 | 2023 | 0 | |
| 5 | 2023 | 10 | |
| 6 | 2023 | 43 | |
| 7 | 2023 | 5 | |
| 8 | A Practical Nomogram for Predicting the Prognosis of Elderly Patients with Gastric Adenocarcinoma After Gastrectomy | 2022 | 3 |
| 9 | 2022 | 0 | |
| 10 | 2022 | 2 | |
| 11 | 2022 | 9 | |
| 12 | 2022 | 2 | |
| 13 | 2022 | 8 | |
| 14 | 2021 | 1 | |
| 15 | 2021 | 43 | |
| 16 | 2020 | 55 | |
| 17 | 2019 | 29 | |
| 18 | 2014 | 1 | |
| 19 | Comparison clinical effect of TE versus CEF regimens as neoadjuvant chemotherapy in the treatment of breast cancer | 2008 | 1 |
| 20 | 1991 | 6 |
About Ji Zhang
Ji Zhang is a scholar working on Cancer Research, Hematology and Molecular Biology, having authored 112 papers that have together received 2.5k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (22 papers), MicroRNA in disease regulation (15 papers), Circular RNAs in diseases (13 papers), RNA modifications and cancer (12 papers), Acute Myeloid Leukemia Research (9 papers), Autophagy in Disease and Therapy (7 papers), Epigenetics and DNA Methylation (6 papers) and Chronic Myeloid Leukemia Treatments (6 papers). The work is most often cited by research in Cancer Research (654 citations), Molecular Biology (1.5k citations) and Oncology (358 citations). Ji Zhang has collaborated with scholars based in China, United States and Ethiopia. Frequent co-authors include Jing Liu, Ting Liu, Daming Ou, Xu Han, Guanmin Jiang, Shunling Yuan, Zhaoping Liu, Jing Zhong, Dingyu Hu and Wenjun Shao. Their work appears in journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.